Total clearances
3
2021-11-16 → 2025-08-13
Name variants in FDA filings: Appliedvr / Appliedvr, Inc.
Trend
Clearance cadence by quarter
Portfolio
Product codes worked
| Code |
Device name |
Class |
Specialty |
Clearances |
Most recent |
| QRA |
Virtual Reality Behavioral Therapy Device For Pain Relief |
Class II |
Neurology |
3 |
2025-08-13 |
Safety
Recalls (1)
Class I (serious)
0
Risk of injury / death
| Date | Severity | Status | Recall # |
Product | Code | Reason |
| 2023-02-27 |
Class II
|
Completed |
Z-2044-2023 |
RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief. |
— |
There is the potential for the program software to malfunction which will not allow it to move forward to the next session. |
Filings
All 510(k) clearances (3)
| Date |
K-number |
Device |
Code |
Class |
Specialty |
| 2025-08-13 |
K251519 |
RelieVRx (Pico G3) |
QRA |
Class II |
Neurology |
| 2024-12-04 |
K243417 |
RelieVRx |
QRA |
Class II |
Neurology |
| 2021-11-16 |
DEN210014 |
EaseVRx |
QRA |
Class II |
Neurology |